Seventy-two hour continuous infusion flavopiridol in relapsed and refractory mantle cell lymphoma

Leukemia and Lymphoma

Volumn 43, Issue 4, 2002, Pages 793-797

  Lin, Thomas S ^a   Howard, Orion M ^a   Neuberg, Donna S ^a   Kim, Helen H ^a   Shipp, Margaret A ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Chemotherapy; Clinical trial; Flavopiridol; Mantel cell lymphoma

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLAVOPIRIDOL; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ANOREXIA; APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RECURRENCE; CELL CYCLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEX FORMATION; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DNA DAMAGE; DRUG RESPONSE; DRUG SAFETY; DRUG TARGETING; DRUG TOLERABILITY; FEMALE; GENE OVEREXPRESSION; HUMAN; IN VITRO STUDY; LYMPHOMA CELL LINE; MALE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL;

AGED; ALKALOIDS; ANTINEOPLASTIC AGENTS; FEMALE; FLAVONOIDS; HUMANS; INFUSIONS, INTRAVENOUS; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; PIPERIDINES; STAUROSPORINE;

EID: 0036240601     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190290016908     Document Type: Article

References (41)

1. "Mantle cell lymphoma: A clinicopathologic study of 80 cases"
2. "Nonfollicular small B-cell lymphomas: A heterogeneous group of patients with district clinical features and outcome"
3. "Mantle cell lymphoma: Presenting features, response to therapy, and prognostic factors"
4. "A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): A Southwest Oncology Group study"
5. "Mantle cell lymphoma: A retrospective study of 121 cases"
6. "Mantle-cell lymphoma: A population-based clinical study"
7. "Mantle cell lymphoma-an entity comes of age"
8. "Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group"
9. "European Lymphoma Task Force (ELTF): Report of the workshop on mantle cell lymphoma (MCL)"
10. "Patterns of survival in mantle cell lymphoma"
11. "Allogeneic hematopoietic transplantation for mantle cell lymphoma: Molecular remissions and evidence of graft-versus-malignancy"
12. "Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: An active regimen for aggressive mantle-cell lymphoma"
13. "Rituximab and CHOP induction therapy for newly diagnosed mantle cell lymphoma: Molecular complete responses are not predictive of progression-free survival"
14. "Efficacy of autologous stem cell transplantation in mantle cell lymphoma: A 3-year follow-up study"
15. "High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: No evidence for long-term remission"
16. "Intensive therapy with peripheral stem cell transplantation in 16 patients with mantle cell lymphoma"
17. "High-dose therapy with stem cell transplantation for mantle cell lymphoma: Results and prognostic factors, a single center experience"
18. "Autologous hematopoietic stem cell transplantation for mantle cell lymphoma"
19. "Non-Hodgkin's lymphomas with t(11;14)(q13:q32): A subset of mantle zone/intermediate lymphocytic lymphoma?"
20. "Chromosome 11q rearrangements in B non-Hodgkin's lymphoma"
21. "Intermediate lymphocytic lymphoma: An immunohistologic study with comparison to other lymphocytic lymphomas"
22. "Inhibition of CDKs as a therapeutic modality"
23. "Preclinical and clinical development of cyclin-dependent kinase modulators"
24. "Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK)2 and CDK4 in human breast carcinoma cells"
25. "Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol"
26. "Growth inhibition with reversible cell cycle arrest carcinoma cells by flavone"
27. "Early induction of apoptosis in hematopoietic cell lines after exposure to flavopiridol"
28. "Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms"
29. "Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma"
30. "A phase II trial of the cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non-small cell lung cancer"
31. "Flavopiridol, a novel cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non small cell lung cancer"
32. "Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea"
33. "Flavopiridol sensitivity of chronic lymphocytic leukemia (CLL) cells in vitro varies based upon species drug protein binding"
34. "Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: The importance of sequence of administration"
35. "Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells"
36. "7-Hydroxystauroosporine (UCN-01) causes redistribution of proliferating cell nuclear antigen and abrogates cisplatin-induced S-phase arrest in Chinese hamster ovary cells"
37. "UCN-01 abrogates G2 arrest through a cdc2-dependent pathway that is associated with inactivation of the Wee1Hu kinase and activation of the cdc25c phosphatase"
38. "UCN-01 enhances the in vitro toxicity of clinical agents in human tumor cell lines"
39. "Enhancement of cisplatin-induced cytotoxicity by 7-hydroxystaurosporine (UCN-01), a new G2-checkpoint inhibitor"
40. "The effect of UCN-01(7-hydroxystaurosporine), a potent inhibitor of protein kinase C, on fractionated radiotherapy or daily chemotherapy of a murine fibrosarcoma"
41. "Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms"